-
1
-
-
24644439190
-
Trends in the leading causes of death in the United States, 1970-2002
-
10.1001/jama.294.10.1255, 16160134
-
Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005, 294(10):1255-1259. 10.1001/jama.294.10.1255, 16160134.
-
(2005)
JAMA
, vol.294
, Issue.10
, pp. 1255-1259
-
-
Jemal, A.1
Ward, E.2
Hao, Y.3
Thun, M.4
-
2
-
-
17244382334
-
How to predict HCC development in patients with chronic B viral liver disease?
-
10.1159/000082091, 15785086
-
Han KH, Ahn SH. How to predict HCC development in patients with chronic B viral liver disease?. Intervirology 2005, 48(1):23-28. 10.1159/000082091, 15785086.
-
(2005)
Intervirology
, vol.48
, Issue.1
, pp. 23-28
-
-
Han, K.H.1
Ahn, S.H.2
-
3
-
-
52049096005
-
Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis
-
10.1002/cncr.23684, 18615601
-
Han KH, Seong J, Kim JK, Ahn SH, Lee do Y, Chon CY. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis. Cancer 2008, 113(5):995-1003. 10.1002/cncr.23684, 18615601.
-
(2008)
Cancer
, vol.113
, Issue.5
, pp. 995-1003
-
-
Han, K.H.1
Seong, J.2
Kim, J.K.3
Ahn, S.H.4
Lee do, Y.5
Chon, C.Y.6
-
4
-
-
77954487817
-
Hepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma
-
Ueshima K, Kudo M, Takita M, Nagai T, Tatsumi C, Ueda T, Kitai S, Ishikawa E, Yada N, Inoue T, et al. Hepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma. Oncology 2010, 78(Suppl 1):148-153.
-
(2010)
Oncology
, vol.78
, Issue.SUPPL. 1
, pp. 148-153
-
-
Ueshima, K.1
Kudo, M.2
Takita, M.3
Nagai, T.4
Tatsumi, C.5
Ueda, T.6
Kitai, S.7
Ishikawa, E.8
Yada, N.9
Inoue, T.10
-
5
-
-
0037129704
-
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
-
10.1016/S0140-6736(02)08649-X, 12049862
-
Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Sola R, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002, 359(9319):1734-1739. 10.1016/S0140-6736(02)08649-X, 12049862.
-
(2002)
Lancet
, vol.359
, Issue.9319
, pp. 1734-1739
-
-
Llovet, J.M.1
Real, M.I.2
Montana, X.3
Planas, R.4
Coll, S.5
Aponte, J.6
Ayuso, C.7
Sala, M.8
Muchart, J.9
Sola, R.10
-
6
-
-
22244457397
-
Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm
-
10.1097/01.RVI.0000161377.33557.20, 16002503
-
Maluccio M, Covey AM, Gandhi R, Gonen M, Getrajdman GI, Brody LA, Fong Y, Jarnagin W, D'Angelica M, Blumgart L, et al. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm. J Vasc Interv Radiol 2005, 16(7):955-961. 10.1097/01.RVI.0000161377.33557.20, 16002503.
-
(2005)
J Vasc Interv Radiol
, vol.16
, Issue.7
, pp. 955-961
-
-
Maluccio, M.1
Covey, A.M.2
Gandhi, R.3
Gonen, M.4
Getrajdman, G.I.5
Brody, L.A.6
Fong, Y.7
Jarnagin, W.8
D'Angelica, M.9
Blumgart, L.10
-
7
-
-
44149096218
-
Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma
-
10.1016/j.jvir.2008.02.013, 18503900
-
Maluccio MA, Covey AM, Porat LB, Schubert J, Brody LA, Sofocleous CT, Getrajdman GI, Jarnagin W, Dematteo R, Blumgart LH, et al. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 2008, 19(6):862-869. 10.1016/j.jvir.2008.02.013, 18503900.
-
(2008)
J Vasc Interv Radiol
, vol.19
, Issue.6
, pp. 862-869
-
-
Maluccio, M.A.1
Covey, A.M.2
Porat, L.B.3
Schubert, J.4
Brody, L.A.5
Sofocleous, C.T.6
Getrajdman, G.I.7
Jarnagin, W.8
Dematteo, R.9
Blumgart, L.H.10
-
8
-
-
0036741728
-
Chemoembolization of hepatocellular carcinoma
-
Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF. Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2002, 13(9 Pt 2):S211-221.
-
(2002)
J Vasc Interv Radiol
, vol.13
, Issue.9 PART 2
-
-
Ramsey, D.E.1
Kernagis, L.Y.2
Soulen, M.C.3
Geschwind, J.F.4
-
9
-
-
42449143876
-
Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy
-
10.1148/radiol.2471070818, 18305190
-
Yamakado K, Nakatsuka A, Takaki H, Yokoi H, Usui M, Sakurai H, Isaji S, Shiraki K, Fuke H, Uemoto S, et al. Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 2008, 247(1):260-266. 10.1148/radiol.2471070818, 18305190.
-
(2008)
Radiology
, vol.247
, Issue.1
, pp. 260-266
-
-
Yamakado, K.1
Nakatsuka, A.2
Takaki, H.3
Yokoi, H.4
Usui, M.5
Sakurai, H.6
Isaji, S.7
Shiraki, K.8
Fuke, H.9
Uemoto, S.10
-
10
-
-
54949157603
-
Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors
-
10.1007/s00432-008-0410-6, 18483745
-
Kim SU, Kim do Y, Park JY, Ahn SH, Nah HJ, Chon CY, Han KH. Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors. J Cancer Res Clin Oncol 2008, 134(12):1377-1384. 10.1007/s00432-008-0410-6, 18483745.
-
(2008)
J Cancer Res Clin Oncol
, vol.134
, Issue.12
, pp. 1377-1384
-
-
Kim, S.U.1
Kim do, Y.2
Park, J.Y.3
Ahn, S.H.4
Nah, H.J.5
Chon, C.Y.6
Han, K.H.7
-
11
-
-
47949116252
-
Sorafenib in advanced hepatocellular carcinoma
-
10.1056/NEJMoa0708857, 18650514
-
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008, 359(4):378-390. 10.1056/NEJMoa0708857, 18650514.
-
(2008)
N Engl J Med
, vol.359
, Issue.4
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
Hilgard, P.4
Gane, E.5
Blanc, J.F.6
de Oliveira, A.C.7
Santoro, A.8
Raoul, J.L.9
Forner, A.10
-
12
-
-
0037308133
-
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
-
10.1053/jhep.2003.50047, 12540794
-
Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003, 37(2):429-442. 10.1053/jhep.2003.50047, 12540794.
-
(2003)
Hepatology
, vol.37
, Issue.2
, pp. 429-442
-
-
Llovet, J.M.1
Bruix, J.2
-
13
-
-
0036237822
-
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
-
10.1053/jhep.2002.33156, 11981766
-
Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002, 35(5):1164-1171. 10.1053/jhep.2002.33156, 11981766.
-
(2002)
Hepatology
, vol.35
, Issue.5
, pp. 1164-1171
-
-
Lo, C.M.1
Ngan, H.2
Tso, W.K.3
Liu, C.L.4
Lam, C.M.5
Poon, R.T.6
Fan, S.T.7
Wong, J.8
-
14
-
-
0017696861
-
Serum alphafetoprotein in hepatocellular carcinoma
-
10.1002/1097-0142(197708)40:2<779::AID-CNCR2820400227>3.0.CO;2-Y, 70268
-
Chen DS, Sung JL. Serum alphafetoprotein in hepatocellular carcinoma. Cancer 1977, 40(2):779-783. 10.1002/1097-0142(197708)40:2<779::AID-CNCR2820400227>3.0.CO;2-Y, 70268.
-
(1977)
Cancer
, vol.40
, Issue.2
, pp. 779-783
-
-
Chen, D.S.1
Sung, J.L.2
-
15
-
-
0016561094
-
Proceedings: Serum alphafetoprotein levels in liver disease: relation to hepatocellular regeneration and development of hepatoma
-
Eleftheriou N, Thomas H, Heathcote J, Sherlock S. Proceedings: Serum alphafetoprotein levels in liver disease: relation to hepatocellular regeneration and development of hepatoma. Gut 1975, 16(10):835.
-
(1975)
Gut
, vol.16
, Issue.10
, pp. 835
-
-
Eleftheriou, N.1
Thomas, H.2
Heathcote, J.3
Sherlock, S.4
-
16
-
-
0029124120
-
Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study
-
Izuno K, Fujiyama S, Yamasaki K, Sato M, Sato T. Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study. Hepatogastroenterology 1995, 42(4):387-393.
-
(1995)
Hepatogastroenterology
, vol.42
, Issue.4
, pp. 387-393
-
-
Izuno, K.1
Fujiyama, S.2
Yamasaki, K.3
Sato, M.4
Sato, T.5
-
17
-
-
0028158071
-
Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis
-
10.1016/S0168-8278(05)80468-4, 7515408
-
Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, Coderc E, Reboullet P, Beaugrand M. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994, 20(1):65-71. 10.1016/S0168-8278(05)80468-4, 7515408.
-
(1994)
J Hepatol
, vol.20
, Issue.1
, pp. 65-71
-
-
Pateron, D.1
Ganne, N.2
Trinchet, J.C.3
Aurousseau, M.H.4
Mal, F.5
Meicler, C.6
Coderc, E.7
Reboullet, P.8
Beaugrand, M.9
-
18
-
-
0035056663
-
Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status
-
10.1016/S0168-8278(00)00053-2, 11394657
-
Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, Domenicali M, De Notariis S, Roda E, Bernardi M. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001, 34(4):570-575. 10.1016/S0168-8278(00)00053-2, 11394657.
-
(2001)
J Hepatol
, vol.34
, Issue.4
, pp. 570-575
-
-
Trevisani, F.1
D'Intino, P.E.2
Morselli-Labate, A.M.3
Mazzella, G.4
Accogli, E.5
Caraceni, P.6
Domenicali, M.7
De Notariis, S.8
Roda, E.9
Bernardi, M.10
-
19
-
-
0029839931
-
Efficacy of a surveillance program for early detection of hepatocellular carcinoma
-
10.1002/(SICI)1097-0142(19960901)78:5<977::AID-CNCR6>3.0.CO;2-9, 8780534
-
Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996, 78(5):977-985. 10.1002/(SICI)1097-0142(19960901)78:5<977::AID-CNCR6>3.0.CO;2-9, 8780534.
-
(1996)
Cancer
, vol.78
, Issue.5
, pp. 977-985
-
-
Zoli, M.1
Magalotti, D.2
Bianchi, G.3
Gueli, C.4
Marchesini, G.5
Pisi, E.6
-
20
-
-
67649992397
-
NCCN clinical practice guidelines in oncology: hepatobiliary cancers
-
Benson AB, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, Covey A, Curley SA, D'Angelica MI, Davila R, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw 2009, 7(4):350-391.
-
(2009)
J Natl Compr Canc Netw
, vol.7
, Issue.4
, pp. 350-391
-
-
Benson, A.B.1
Abrams, T.A.2
Ben-Josef, E.3
Bloomston, P.M.4
Botha, J.F.5
Clary, B.M.6
Covey, A.7
Curley, S.A.8
D'Angelica, M.I.9
Davila, R.10
-
21
-
-
0034898897
-
Resection of hepatocellular carcinoma without preoperative tumor biopsy
-
10.1097/00000658-200108000-00010, 1422007, 11505066
-
Levy I, Greig PD, Gallinger S, Langer B, Sherman M. Resection of hepatocellular carcinoma without preoperative tumor biopsy. Ann Surg 2001, 234(2):206-209. 10.1097/00000658-200108000-00010, 1422007, 11505066.
-
(2001)
Ann Surg
, vol.234
, Issue.2
, pp. 206-209
-
-
Levy, I.1
Greig, P.D.2
Gallinger, S.3
Langer, B.4
Sherman, M.5
-
22
-
-
0032862122
-
Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy
-
10.1002/hep.510300411, 10498639
-
Torzilli G, Minagawa M, Takayama T, Inoue K, Hui AM, Kubota K, Ohtomo K, Makuuchi M. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999, 30(4):889-893. 10.1002/hep.510300411, 10498639.
-
(1999)
Hepatology
, vol.30
, Issue.4
, pp. 889-893
-
-
Torzilli, G.1
Minagawa, M.2
Takayama, T.3
Inoue, K.4
Hui, A.M.5
Kubota, K.6
Ohtomo, K.7
Makuuchi, M.8
-
23
-
-
58749090909
-
New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy
-
Chan SL, Mo FK, Johnson PJ, Hui EP, Ma BB, Ho WM, Lam KC, Chan AT, Mok TS, Yeo W. New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy. J Clin Oncol 2009, 27(3):446-452.
-
(2009)
J Clin Oncol
, vol.27
, Issue.3
, pp. 446-452
-
-
Chan, S.L.1
Mo, F.K.2
Johnson, P.J.3
Hui, E.P.4
Ma, B.B.5
Ho, W.M.6
Lam, K.C.7
Chan, A.T.8
Mok, T.S.9
Yeo, W.10
-
24
-
-
68449100731
-
Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma
-
10.1634/theoncologist.2009-0038, 19581525
-
Vora SR, Zheng H, Stadler ZK, Fuchs CS, Zhu AX. Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma. Oncologist 2009, 14(7):717-725. 10.1634/theoncologist.2009-0038, 19581525.
-
(2009)
Oncologist
, vol.14
, Issue.7
, pp. 717-725
-
-
Vora, S.R.1
Zheng, H.2
Stadler, Z.K.3
Fuchs, C.S.4
Zhu, A.X.5
-
25
-
-
70349222999
-
Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?
-
10.2217/fon.09.64, 19663737
-
Chan SL, Chan AT, Yeo W. Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?. Future Oncol 2009, 5(6):889-899. 10.2217/fon.09.64, 19663737.
-
(2009)
Future Oncol
, vol.5
, Issue.6
, pp. 889-899
-
-
Chan, S.L.1
Chan, A.T.2
Yeo, W.3
-
26
-
-
79551521168
-
Early alpha-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma
-
10.1111/j.1478-3231.2010.02368.x, 21083802
-
Kim BK, Ahn SH, Seong JS, Park JY, Kim do Y, Kim JK, Lee do Y, Lee KH, Han KH. Early alpha-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma. Liver Int 2011, 31(3):369-376. 10.1111/j.1478-3231.2010.02368.x, 21083802.
-
(2011)
Liver Int
, vol.31
, Issue.3
, pp. 369-376
-
-
Kim, B.K.1
Ahn, S.H.2
Seong, J.S.3
Park, J.Y.4
Kim do, Y.5
Kim, J.K.6
Lee do, Y.7
Lee, K.H.8
Han, K.H.9
-
27
-
-
73349142702
-
Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival
-
10.1200/JCO.2009.23.1282, 19805671
-
Riaz A, Ryu RK, Kulik LM, Mulcahy MF, Lewandowski RJ, Minocha J, Ibrahim SM, Sato KT, Baker T, Miller FH, et al. Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival. J Clin Oncol 2009, 27(34):5734-5742. 10.1200/JCO.2009.23.1282, 19805671.
-
(2009)
J Clin Oncol
, vol.27
, Issue.34
, pp. 5734-5742
-
-
Riaz, A.1
Ryu, R.K.2
Kulik, L.M.3
Mulcahy, M.F.4
Lewandowski, R.J.5
Minocha, J.6
Ibrahim, S.M.7
Sato, K.T.8
Baker, T.9
Miller, F.H.10
-
28
-
-
0036297393
-
Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma
-
Fujiyama S, Tanaka M, Maeda S, Ashihara H, Hirata R, Tomita K. Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma. Oncology 2002, 62(Suppl 1):57-63.
-
(2002)
Oncology
, vol.62
, Issue.SUPPL. 1
, pp. 57-63
-
-
Fujiyama, S.1
Tanaka, M.2
Maeda, S.3
Ashihara, H.4
Hirata, R.5
Tomita, K.6
-
29
-
-
7244250405
-
Angiogenesis and hepatocellular carcinoma
-
10.1016/j.jhep.2004.09.006, 15519663
-
Semela D, Dufour JF. Angiogenesis and hepatocellular carcinoma. J Hepatol 2004, 41(5):864-880. 10.1016/j.jhep.2004.09.006, 15519663.
-
(2004)
J Hepatol
, vol.41
, Issue.5
, pp. 864-880
-
-
Semela, D.1
Dufour, J.F.2
-
30
-
-
77958089831
-
Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population
-
10.1007/s12072-010-9186-2, 2940002, 21063479
-
Sharma B, Srinivasan R, Chawla YK, Kapil S, Saini N, Singla B, Chakraborthy A, Kalra N, Duseja A, Dhiman RK. Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population. Hepatol Int 2010, 4(3):569-576. 10.1007/s12072-010-9186-2, 2940002, 21063479.
-
(2010)
Hepatol Int
, vol.4
, Issue.3
, pp. 569-576
-
-
Sharma, B.1
Srinivasan, R.2
Chawla, Y.K.3
Kapil, S.4
Saini, N.5
Singla, B.6
Chakraborthy, A.7
Kalra, N.8
Duseja, A.9
Dhiman, R.K.10
-
31
-
-
67649305155
-
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma
-
10.1053/j.gastro.2009.04.005, 2704256, 19362088
-
Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, et al. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology 2009, 137(1):110-118. 10.1053/j.gastro.2009.04.005, 2704256, 19362088.
-
(2009)
Gastroenterology
, vol.137
, Issue.1
, pp. 110-118
-
-
Marrero, J.A.1
Feng, Z.2
Wang, Y.3
Nguyen, M.H.4
Befeler, A.S.5
Roberts, L.R.6
Reddy, K.R.7
Harnois, D.8
Llovet, J.M.9
Normolle, D.10
-
32
-
-
28844480321
-
Management of hepatocellular carcinoma
-
10.1002/hep.20933, 16250051
-
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42(5):1208-1236. 10.1002/hep.20933, 16250051.
-
(2005)
Hepatology
, vol.42
, Issue.5
, pp. 1208-1236
-
-
Bruix, J.1
Sherman, M.2
-
33
-
-
84867081369
-
Combined measurement of preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma
-
10.1002/ijc.27507, 22362471
-
Chon YE, Choi GH, Lee MH, Kim SU, Kim DY, Ahn SH, Kim KS, Choi JS, Han KH, Chon CY, et al. Combined measurement of preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma. Int J Cancer 2012, 131(10):2332-2341. 10.1002/ijc.27507, 22362471.
-
(2012)
Int J Cancer
, vol.131
, Issue.10
, pp. 2332-2341
-
-
Chon, Y.E.1
Choi, G.H.2
Lee, M.H.3
Kim, S.U.4
Kim, D.Y.5
Ahn, S.H.6
Kim, K.S.7
Choi, J.S.8
Han, K.H.9
Chon, C.Y.10
-
34
-
-
36549007486
-
Computed tomography-an increasing source of radiation exposure
-
10.1056/NEJMra072149, 18046031
-
Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007, 357(22):2277-2284. 10.1056/NEJMra072149, 18046031.
-
(2007)
N Engl J Med
, vol.357
, Issue.22
, pp. 2277-2284
-
-
Brenner, D.J.1
Hall, E.J.2
-
35
-
-
67651097586
-
Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study
-
10.1097/MCG.0b013e318182015a, 19197197
-
Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study. J Clin Gastroenterol 2009, 43(5):482-488. 10.1097/MCG.0b013e318182015a, 19197197.
-
(2009)
J Clin Gastroenterol
, vol.43
, Issue.5
, pp. 482-488
-
-
Kim, H.S.1
Park, J.W.2
Jang, J.S.3
Kim, H.J.4
Shin, W.G.5
Kim, K.H.6
Lee, J.H.7
Kim, H.Y.8
Jang, M.K.9
-
36
-
-
84862924426
-
Early on-treatment predictions of clinical outcomes using AFP and DCP responses in patients with advanced hepatocellular carcinoma
-
10.1111/j.1440-1746.2011.06867.x, 21793906
-
Lee MH, Kim SU, Kim DY, Ahn SH, Choi EH, Lee KH, Lee DY, Seong J, Han KH, Chon CY, et al. Early on-treatment predictions of clinical outcomes using AFP and DCP responses in patients with advanced hepatocellular carcinoma. J Gastroenterol Hepatol 2012, 27(2):313-322. 10.1111/j.1440-1746.2011.06867.x, 21793906.
-
(2012)
J Gastroenterol Hepatol
, vol.27
, Issue.2
, pp. 313-322
-
-
Lee, M.H.1
Kim, S.U.2
Kim, D.Y.3
Ahn, S.H.4
Choi, E.H.5
Lee, K.H.6
Lee, D.Y.7
Seong, J.8
Han, K.H.9
Chon, C.Y.10
-
37
-
-
77957559384
-
Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma
-
10.1002/cncr.25257, 20572033
-
Shao YY, Lin ZZ, Hsu C, Shen YC, Hsu CH, Cheng AL. Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma. Cancer 2010, 116(19):4590-4596. 10.1002/cncr.25257, 20572033.
-
(2010)
Cancer
, vol.116
, Issue.19
, pp. 4590-4596
-
-
Shao, Y.Y.1
Lin, Z.Z.2
Hsu, C.3
Shen, Y.C.4
Hsu, C.H.5
Cheng, A.L.6
-
38
-
-
84864724045
-
An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer
-
10.1002/jso.23073, 22389029
-
Liu X, Sheng W, Wang Y. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer. J Surg Oncol 2012, 106(3):299-303. 10.1002/jso.23073, 22389029.
-
(2012)
J Surg Oncol
, vol.106
, Issue.3
, pp. 299-303
-
-
Liu, X.1
Sheng, W.2
Wang, Y.3
-
39
-
-
0031782818
-
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators
-
Manghisi O, Elba S, Mossa A, Giorgio A, Aloisio V, Perrotta A, Tardio B, Naja CD, Caturelli E, Calandra M, et al. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998, 28(3):751-755.
-
(1998)
Hepatology
, vol.28
, Issue.3
, pp. 751-755
-
-
Manghisi, O.1
Elba, S.2
Mossa, A.3
Giorgio, A.4
Aloisio, V.5
Perrotta, A.6
Tardio, B.7
Naja, C.D.8
Caturelli, E.9
Calandra, M.10
-
40
-
-
0024429682
-
Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients
-
10.1002/1097-0142(19891015)64:8<1700::AID-CNCR2820640824>3.0.CO;2-Z, 2477133
-
Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer 1989, 64(8):1700-1707. 10.1002/1097-0142(19891015)64:8<1700::AID-CNCR2820640824>3.0.CO;2-Z, 2477133.
-
(1989)
Cancer
, vol.64
, Issue.8
, pp. 1700-1707
-
-
Nomura, F.1
Ohnishi, K.2
Tanabe, Y.3
-
41
-
-
77957110435
-
Time-dependent analysis of predisposing factors for the recurrence of hepatocellular carcinoma
-
Iwadou S, Nouso K, Kuwaki K, Kobayashi Y, Nakamura S, Tanaka H, Miyoshi K, Ohnishi H, Miyake Y, Shiraha H, et al. Time-dependent analysis of predisposing factors for the recurrence of hepatocellular carcinoma. Liver Int 2010, 30(7):1027-1032.
-
(2010)
Liver Int
, vol.30
, Issue.7
, pp. 1027-1032
-
-
Iwadou, S.1
Nouso, K.2
Kuwaki, K.3
Kobayashi, Y.4
Nakamura, S.5
Tanaka, H.6
Miyoshi, K.7
Ohnishi, H.8
Miyake, Y.9
Shiraha, H.10
-
42
-
-
0041627705
-
Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma
-
Tang W, Miki K, Kokudo N, Sugawara Y, Imamura H, Minagawa M, Yuan LW, Ohnishi S, Makuuchi M. Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma. Int J Oncol 2003, 22(5):969-975.
-
(2003)
Int J Oncol
, vol.22
, Issue.5
, pp. 969-975
-
-
Tang, W.1
Miki, K.2
Kokudo, N.3
Sugawara, Y.4
Imamura, H.5
Minagawa, M.6
Yuan, L.W.7
Ohnishi, S.8
Makuuchi, M.9
-
43
-
-
80051786165
-
Prognostic significance of serum gamma-glutamyl transferase in patients with intermediate hepatocellular carcinoma treated with transcatheter arterial chemoembolization
-
10.1097/MEG.0b013e32834902dd, 21730869
-
Zhang JB, Chen Y, Zhang B, Xie X, Zhang L, Ge N, Ren Z, Ye SL. Prognostic significance of serum gamma-glutamyl transferase in patients with intermediate hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Eur J Gastroenterol Hepatol 2011, 23(9):787-793. 10.1097/MEG.0b013e32834902dd, 21730869.
-
(2011)
Eur J Gastroenterol Hepatol
, vol.23
, Issue.9
, pp. 787-793
-
-
Zhang, J.B.1
Chen, Y.2
Zhang, B.3
Xie, X.4
Zhang, L.5
Ge, N.6
Ren, Z.7
Ye, S.L.8
-
44
-
-
0142039148
-
Different mechanisms for gamma-glutamyltransferase-dependent resistance to carboplatin and cisplatin
-
10.1016/S0006-2952(03)00343-5, 12906924
-
Daubeuf S, Balin D, Leroy P, Visvikis A. Different mechanisms for gamma-glutamyltransferase-dependent resistance to carboplatin and cisplatin. Biochem Pharmacol 2003, 66(4):595-604. 10.1016/S0006-2952(03)00343-5, 12906924.
-
(2003)
Biochem Pharmacol
, vol.66
, Issue.4
, pp. 595-604
-
-
Daubeuf, S.1
Balin, D.2
Leroy, P.3
Visvikis, A.4
-
45
-
-
4444246307
-
Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress?
-
10.1016/j.freeradbiomed.2004.06.032, 15336318
-
Lim JS, Yang JH, Chun BY, Kam S, Jacobs DR, Lee DH. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress?. Free Radic Biol Med 2004, 37(7):1018-1023. 10.1016/j.freeradbiomed.2004.06.032, 15336318.
-
(2004)
Free Radic Biol Med
, vol.37
, Issue.7
, pp. 1018-1023
-
-
Lim, J.S.1
Yang, J.H.2
Chun, B.Y.3
Kam, S.4
Jacobs, D.R.5
Lee, D.H.6
-
46
-
-
84862182834
-
Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels
-
10.1097/MEG.0b013e3283535c34, 22495400
-
Kang SH, Kim do Y, Jeon SM, Ahn SH, Park JY, Kim SU, Kim JK, Lee KS, Chon CY, Han KH. Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels. Eur J Gastroenterol Hepatol 2012, 24(7):849-856. 10.1097/MEG.0b013e3283535c34, 22495400.
-
(2012)
Eur J Gastroenterol Hepatol
, vol.24
, Issue.7
, pp. 849-856
-
-
Kang, S.H.1
Kim do, Y.2
Jeon, S.M.3
Ahn, S.H.4
Park, J.Y.5
Kim, S.U.6
Kim, J.K.7
Lee, K.S.8
Chon, C.Y.9
Han, K.H.10
-
47
-
-
84864309581
-
Long-term outcome of transcatheter subsegmental and segmental arterial chemoemobolization using lipiodol for hepatocellular carcinoma
-
10.1007/s00270-011-0224-9, 21739345
-
Takaki S, Sakaguchi H, Anai H, Tanaka T, Yamamoto K, Morimoto K, Nishiofuku H, Inoue M, Sueyoshi S, Nagata T, et al. Long-term outcome of transcatheter subsegmental and segmental arterial chemoemobolization using lipiodol for hepatocellular carcinoma. Cardiovasc Intervent Radiol 2012, 35(3):544-554. 10.1007/s00270-011-0224-9, 21739345.
-
(2012)
Cardiovasc Intervent Radiol
, vol.35
, Issue.3
, pp. 544-554
-
-
Takaki, S.1
Sakaguchi, H.2
Anai, H.3
Tanaka, T.4
Yamamoto, K.5
Morimoto, K.6
Nishiofuku, H.7
Inoue, M.8
Sueyoshi, S.9
Nagata, T.10
|